On August 4, 2021 Gennao Bio, a privately held genetic medicines company developing first-in-class, targeted nucleic acid therapeutics, reported that management will participate in the 2021 Wedbush PacGrow Healthcare Conference, being held virtually from August 10-11, 2021 (Press release, Gennao Bio, AUG 4, 2021, View Source [SID1234585741]). The details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: 2021 Wedbush PacGrow Healthcare Conference
Panel: So Let it Be (Re)Written – Updates in Gene Modulation
Location: Virtual
Date: Tuesday, August 10, 2021
Time: 9:10 AM ET

Members of the Gennao Bio management team will also host investor meetings during the conference.

A live webcast of the panel discussion will be available on the company’s website at www.gennao.com. A replay of the webcast will also be available for 30 days shortly after the conclusion of the event.